4 IBD IVS — Credit Rating and Financial Key Figures

4 IBD IVS (CVR number: 37446939) is a company from RINGKØBING-SKJERN. The company recorded a gross profit of 62.3 kDKK in 2017. The operating profit was -38.6 kDKK, while net earnings were -39.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -31.2 %, which can be considered poor and Return on Equity (ROE) was -69.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 66 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. 4 IBD IVS's liquidity measured by quick ratio was 2.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.